BD Pharmingen™ PE Mouse anti-Human IFN-α[2b]

PROCEDURE

Please refer to chart in Suggested Companion Products section for names and sources of materials used in the following protocol

Cell Activation

Note: The following procedures need to be performed in the hood using aseptic technique.

        1.    Isolate fresh human peripheral blood mononuclear cells PBMC from 60ml of fresh blood, and wash 2X with sterile 1 X PBS. Centrifuge                the cells at 250 Xg for 10 minutes and discard the supernatant.

        2.    Suspend the cells in complete medium (RPMI supplimented with 1% Pen/Strep, 1% L-glutamine and 10% FBS). Count and adjust

               the cell concentration to 2-3 million cells/mL.

        3.    Label two sterile 50-mL conical tubes as "Not Stimulated" and "Stimulated with CPG". Dispense PBMC to each tube (2 million cells/ml).

        4.    Add 5µg of CPG oligodeoxynucleotide per ml of cells to the "Stimulated with CPG" tube.   Cap the tube and vortex gently.

        5.    Incubate both tubes for 2 hours at 37°C.

        6.    Dilute BD FastImmune™ Brefeldin A (BFA) 1 to 10 in sterile 1 X PBS.  

        7.    Add 20µl of 1X BFA per ml to both tubes (stimulated and unstimulated). Incubate tubes at 37°C for 2 hours.

                Note: Keep both CPG and BFA aliquots at -20°C.  

        8.    Add 100µl of 20 mM EDTA per mL of cells to both tubes and incubate overnight at 4°C.                

Surface and Intracellular Staining

        9.    Centrifuge the two tubes at 250 X g for 10 minutes. Discard the supernatants by aspiration and re-suspend cells in 25 ml of

               BD FACS Wash Buffer

        10.  Centrifuge the tubes at 250 X g for 10 minutes.  Discard the supernatants and re-suspend cells in FACS Wash buffer at 20 million cells/ml.

        11.  Label 12x75mm polypropylene tubes appropriately. Add 100 µl of cells (2 million cells/test) to each tube.

        12.  Add surface staining antibodies to each tube (human Lin-1 FITC, human CD123 PerCPCy5.5, and human HLA-DR APC or

               PE conjugate). Incubate the tubes at room temperature for 30 minutes in the dark.

        13.  Following incubation, add 2 ml of cold FACS Wash Buffer to each tube and centrifuge at 250 X g for 10 minutes.  

               Discard the supernatants by aspiration and vortex the pellets to re-suspend the cells.

        14.  Add 1 ml of room temperature BD Cytofix/Cytoperm Buffer to each tube. Mix well and incubate at room temperature in the

               dark for 30 minutes.

        15.  Add 2 ml of cold BD Perm/Wash Buffer to each tube and centrifuge at 500 X g for 5 minutes; discard the supernatants

               by aspiration and vortex the pellets to re-suspend cells.

        16.  Add intracellular staining antibody anti-human IFN-alpha (20µl/test) or the proper isotype control at the appropriate

               volume per test to the tubes and mix well by vortexing.  Bring test volume to 100µl using cold BD Perm/Wash Buffer.

               Incubate tubes at room temperature for 60 minutes in the dark.

        17.  Add 2 ml of cold BD Perm/Wash Buffer to each tube and centrifuge at 500 X g for 5 minutes; discard supernatant

               by aspiration and vortex pellet to suspend cells.

        18.  Add 300µl of cold BD Perm/Wash Buffer to each tube for immediate flow cytometric analysis.

                Optional:  Re-suspend the pellets with 200µl of cold 1% -formaldehyde  and keep the tubes at 4°C in the dark up to 24 hours                         before flow cytometry. If storing longer than 24 hours, we recommend washing cells in wash buffer as extended incubation with                         fixatives might affect fluorochromes.

Flow Cytometry and Data Analysis

Acquire at least 500,000 events (lymphocytes and monocytes).

A sequential gating strategy is required for successful data analysis:

        1.    Gate tightly on the lymphocytes and monocytes using scatter profiles.

        2.    View the Lin-1 versus HLA-DR profile of the gated lymphocytes and monocytes, and select the Lin-1-negative, HLA-DR-positive                          population (R2 in the figure).  Be sure not to include any of the Lin-1-positive cells.

        3.    View the IFN-  versus CD123 profile of the gated cells to detect the IFN- -positive population.

Unstimulated sample is used as a negative control could also be used to set the markers.

Open up the second gate on Lin-1- HLA-DR+(R2) and from there open up the third gate for CD123+ IFN-alpha+(R3). Acquire about 150-200 events in CD123+ IFN-alpha+ double positive quadrant (R3). See below for correct and incorrect gating examples.

The proper gating for IFN-alpha is crucial for proper analysis.  Below are two examples. The first example is how we recommend gating for proper detection of IFN-alpha.  The second example is the incorrect way to gate for IFN-alpha.

1. This reagent has been pre-diluted for use at the recommended Volume per Test. We typically use 1 × 10^6 cells in a 100-µl experimental sample (a test).
2. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
3. Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
4. For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.
5. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
6. Source of all serum proteins is from USDA inspected abattoirs located in the United States.